Classifications for Carcinogenesis of Antitumoral Drugs

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4, 2003, Pages 651-672

  Binetti, Roberto ^a   Costamagna, F M ^a   Marcello, I ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antineoplastic drug; Carcinogens; Classification; International Agencies

Indexed keywords

ALKYLATING AGENT; ALLOPURINOL; ALTRETAMINE; AMIFOSTINE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; AZACITIDINE; AZASERINE; BLEOMYCIN; BUSULFAN; CAPECITABINE; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXIFLURIDINE; DOXORUBICIN; EPIRUBICIN; ESTRAMUSTINE PHOSPHATE; ETOPOSIDE; FLUDARABINE PHOSPHATE; FLUOROURACIL; FOLINA; FOLINATE CALCIUM; FOTEMUSTINE; GEMCITABINE; HEXINAWAS; HYDROXYUREA; IDARUBICIN; IFOSFAMIDE; LOMUSTINE; MELPHALAN; MERCAPTOPURINE; MILOSAR; MITHRAMYCIN; MITOBRONITOL; MITOXANTRONE; ONKOTRONE; OXALIPLATIN; PACLITAXEL; PRAVA; PREDNIMUSTINE; PROCARBAZINE; RALTITREXED; RAZOXANE; STREPTOZOCIN; TAXANE DERIVATIVE; TEGAFUR; TEMOZOLOMIDE; THIOTEPA; TRIMETREXATE GLUCURONATE; UNINDEXED DRUG; URICEMIL; VINBLASTINE SULFATE; VINCA ALKALOID; VINDESINE;

ANTINEOPLASTIC ACTIVITY; CANCER RISK; CARCINOGENESIS; CLINICAL PRACTICE; DEVELOPMENTAL DISORDER; DRUG CARCINOGENICITY; DRUG CLASSIFICATION; DRUG EXPOSURE; EPIDEMIOLOGICAL DATA; EUROPEAN UNION; HUMAN; INTERNATIONAL COOPERATION; MUTAGENICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

ANTINEOPLASTIC AGENTS; CARCINOGENS; EUROPEAN UNION; HUMANS; INTERNATIONALITY; INTERNET; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 1242298818     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. EEC (1979) Council Directive 79/831/EEC of 18 September 1979 amending for the sixth time Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances Official Journal L 259, 15/10/1979 at http://europa.eu.int/index_en.htm
2. IARC (2003). International Agency for Research on Cancer. Overall Evaluations of Carcinogenicity to Humans As evaluated in IARC Monographs Volumes 1-82 at http://monographs.iarc.fr/monoeval/crthall.html
3. Report on Carcinogens, Tenth Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, December 2002. at http://ehp.niehs.nih.gov/roc/
4. EEC (1993) Council Regulation 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances. (OJ L 84, 5 April 1993) at http://ecb.jrc.it/existing-chemicals/
5. EINECS (European Inventory of Existing Commercial Chemicals Substances). O.J. C 146A, 15.6.1990 at http://ecb.ei.jrc.it/
6. EEC (1992) Council Directive 92/32/EEC of 30 April 1992 amending for the seventh time Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances Official Journal L 154, 05/06/1992 at http://europa.eu.int/index_en.htm
7. FDA: Pregnancy categories for prescription drugs. FDA Drug Bull. 12:2425, 1982.
8. CCTN (1997) - Report of the activity of the Italian National Advisory Toxicological Committee in 1997. Edited by Ivano Camoni and Nicolina Mucci. Istituto Superiore di Sanità, Roma (Serie Rapporti Interni 97/4).
9. National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction (CERHR). 2000. at http://cerhr.niehs.nih.gov/news/index.html
10. INSC (2002) - Inventario Nazionale delle Sostanze Chimiche (INSC). File on line. Istituto Superiore di Sanità - Roma
11. IARC (1972-2003). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Volume 1 to 82. IARC, Lyon. at: http://www.iarc.fr/
12. International Agency for Research on Cancer (IARC) (1987). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes I to 42 Supplement 7 IARC, Lyon at: http://www.iarc.fr/ ...
13. IARC (1981). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol. 26. Some Antineoplastic and Immunosuppressive Agents. IARC, Lyon. at: http://www.iarc.fr/
14. IARC (1990). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 50. Pharmaceutical Drugs. IARC, Lyon. at: http://www.iarc.fr/
15. IARC (2000). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 76. Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents. IARC, Lyon. at: http://www.iarc.fr/
16. IARC (1975). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol. 9. Some Aziridines, N-, S- & O-Mustards and Selenium. IARC, Lyon. at: http://www.iarc.fr/
17. IARC (1976). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol. 11. Cadmium, Nickel, Some Epoxides, Miscellaneous Industrial Chemicals and General Considerations on Volatile Anaesthetics. IARC, Lyon. at: http://www.iarc.fr/
18. IARC (2003). International Agency for Research on Cancer Preamble to the IARC Monographs. IARC, Lyon. at: http://monographs.iarc.fr/monoeval/preamble.html
19. Tomatis L. The IARC monographs program: changing attitudes towards public health. Int J Occup Environ Health. 2002 Apr-Jun;8(2):144-152.
20. WHO (2002) Essential medicines. WHO Model List (April 2002) Complementary List. Worl Health Organization. http://www.who.int/medicines/organization/par/edl/eml2002c omp.pdf